 |
市场调查报告书
商品编码
1305241
全球小细胞肺癌（SCLC）治疗药物市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测Global Small Cell Lung Cancer (SCLC) Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
小细胞肺癌（SCLC）治疗药物市场的全球需求预计将从2022年的73.2亿美元增长到2030年的212.1亿美元，2023-2030年的复合年增长率为14.22%。
小细胞肺癌（SCLC）治疗是指小细胞肺癌的一系列治疗方法，小细胞肺癌是一种肺癌，通常比其他类型的肺癌生长和扩散更快。由于癌细胞在显微镜下的外观，小细胞肺癌也被称为燕麦细胞癌。这种类型的癌症需要结合化疗、放疗和免疫疗法进行治疗。
市场动态：
SCLC是一种侵袭性很强的肺癌，该病的发病率在全球范围内呈上升趋势。因此，对SCLC治疗药物的需求也在增加。该领域的技术进步为SCLC带来了更具针对性和更有效的疗法，包括免疫疗法和靶向疗法。这些疗法推动了市场增长，改善了患者预后。各国政府、私人机构和制药公司正在增加对癌症研究的投资，这推动了新的SCLC疗法的开发。针对SCLC治疗的优惠报销政策推动了市场增长，因为这使患者更容易获得和负担得起这些治疗。SCLC的早期诊断对于改善患者预后至关重要。随着对早期诊断重要性认识的提高，越来越多的患者在早期阶段得到诊断，这推动了对SCLC治疗药物的需求。
研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球小细胞肺癌（sclc）治疗药物市场的各个细分市场进行了全面评估。小细胞肺癌（sclc）治疗药物行业的增长和趋势为本研究提供了整体方法。
市场细分：
小细胞肺癌（sclc）治疗药物市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。
按治疗类型
- 化疗
- 靶向治疗
- 免疫疗法
- 其他
按终端用户分类
- 医院
- 癌症治疗中心
- 其他（专科诊所）
区域分析
本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区小细胞肺癌（SCLC）治疗药物市场的当前和未来需求。此外，报告还关注了所有主要地区各个应用领域的需求、估计和预测。
- 全球小细胞肺癌（SCLC）治疗药物各地区市场份额（代表图）
- 全球小细胞肺癌（SCLC）治疗药物市场份额
研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。小细胞肺癌（SCLC）治疗药物市场的主要参与者包括ZIOPHARM Oncology、葛兰素史克、梅纳里尼、百时美施贵宝、赛诺菲、诺华、Elekta AB、西门子医疗保健有限公司、G1 Therapeutics。本节包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。
目 录
第一章：前言
- 报告描述
- 报告目标
- 目标受众
- 独特销售主张（USP）和产品
- 研究范围
- 研究方法
- 市场调研流程
- 市场调研方法
第二章：执行摘要
- 市场亮点
- 全球市场概况
第三章：小细胞肺癌（SCLC）治疗药物 - 行业分析
- 简介 - 市场动态
- 市场驱动因素
- 市场限制因素
- 市场机会
- 行业趋势
- 波特五力分析
- 市场吸引力分析
- 按治疗类型分類的市场吸引力分析
- 按最终用户的市场吸引力分析
- 市场吸引力分析：按地区
第四章：价值链分析
- 价值链分析
- 原材料分析
- 原材料清单
- 原材料制造商列表
- 主要原材料价格走势
- 潜在买家名单
- 营销渠道
- 直接营销
- 间接营销
- 营销渠道发展趋势
第五章：covid-19爆发的影响分析
第六章：全球小细胞肺癌（SCLC）治疗药物市场分析：按治疗类型划分
- 治疗类型概述
- 历史和预测数据
- 按治疗类型分析
- 化疗
- 靶向治疗
- 免疫治疗
- 其他治疗
第七章 ：全球小细胞肺癌(SCLC)治疗药物市场分析：按终端用户分类
- 终端用户概述
- 历史和预测数据
- 按最终用户分析
- 医院
- 癌症治疗中心
- 其他（专科诊所）
第8章 : 全球小细胞肺癌（SCLC）治疗药物市场分析：按地区划分
- 地区前景
- 产品介绍
- 北美销售分析
- 概述、历史及预测销售分析
- 北美地区销售分析
- 北美地区各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
- 欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
- 亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区各细分市场销售分析
- 亚太地区各国销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太其他地区销售分析
- 拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
- 中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲各细分市场销售分析
- 中东和非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析
第九章 : 小细胞肺癌（Sclc）治疗药物公司竞争格局
- 小细胞肺癌治疗药物市场竞争格局
- 伙伴关系/合作/协议
- 合并与收购
- 新产品上市
- 其他发展
第10章 : 公司概况
- 顶级公司市场份额分析
- 市场集中度
- ZIOPHARM Oncology
- 公司概况
- 公司收入
- 产品
- 近期发展
- GlaxoSmithKline
- 公司概况
- 公司收入
- 产品
- 近期发展
- Menarini
- 公司概况
- 公司收入
- 产品
- 近期发展
- Bristol-Myers Squibb
- 公司概况
- 公司收入
- 产品
- 近期发展
- Sanofi
- 公司概况
- 公司收入
- 产品
- 近期发展
- Novartis AG
- 公司概况
- 公司收入
- 产品
- 近期发展
- Elekta AB
- 公司概况
- 公司收入
- 产品
- 近期发展
- Siemens Healthcare GmbH
- 公司概况
- 公司收入
- 产品
- 近期发展
- G1 Therapeutics.
- 公司概况
- 公司收入
- 产品
- 近期发展
注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。
The global demand for Small Cell Lung Cancer (SCLC) Therapeutics Market is presumed to reach the market size of nearly USD 21.21 BN by 2030 from USD 7.32 BN in 2022 with a CAGR of 14.22% under the study period 2023 - 2030.
Small Cell Lung Cancer (SCLC) Therapeutics refers to the range of treatments available for small cell lung cancer, a type of lung cancer that typically grows and spreads more quickly than other types of lung cancer. SCLC is also known as oat cell cancer, due to the appearance of the cancer cells under a microscope. This type of cancer is treated with a combination of chemotherapy, radiation therapy, and immunotherapy.
Market Dynamics:
SCLC is a highly aggressive form of lung cancer, and the incidence of the disease is increasing worldwide. As a result, the demand for SCLC therapeutics is also increasing. Technological advancements in the field have led to more targeted and effective therapies for SCLC, including immunotherapy and targeted therapy. These treatments are driving market growth and improving patient outcomes. Governments, private organizations, and pharmaceutical companies are increasing investments in cancer research, which is driving the development of new SCLC therapeutics. The availability of favourable reimbursement policies for SCLC therapeutics is driving market growth, as it makes these treatments more accessible and affordable for patients. Early diagnosis of SCLC is critical for improving patient outcomes. As awareness of the importance of early diagnosis grows, more patients are being diagnosed at an earlier stage, which is driving demand for SCLC therapeutics.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of small cell lung cancer (sclc) therapeutics. The growth and trends of small cell lung cancer (sclc) therapeutics industry provide a holistic approach to this study.
Market Segmentation:
This section of the small cell lung cancer (sclc) therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Treatment Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Others
By End-Users
- Hospitals
- Cancer Therapy Centres
- Others (Speciality Clinics)
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Small Cell Lung Cancer (SCLC) Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
- Global Small Cell Lung Cancer (SCLC) Therapeutics Market Share by Region (Representative Graph)
- Global Small Cell Lung Cancer (SCLC) Therapeutics Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the small cell lung cancer (sclc) therapeutics market include ZIOPHARM Oncology, GlaxoSmithKline, Menarini, Bristol-Myers Squibb, Sanofi, Novartis AG, Elekta AB, Siemens Healthcare GmbH, G1 Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . SMALL CELL LUNG CANCER (SCLC) THERAPEUTICS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By End-Users
- 3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL SMALL CELL LUNG CANCER (SCLC) THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE
- 6.1 Overview by Treatment Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Treatment Type
- 6.4 Chemotherapy Historic and Forecast Sales by Regions
- 6.5 Targeted Therapy Historic and Forecast Sales by Regions
- 6.6 Immunotherapy Historic and Forecast Sales by Regions
- 6.7 Others Historic and Forecast Sales by Regions
7 . GLOBAL SMALL CELL LUNG CANCER (SCLC) THERAPEUTICS MARKET ANALYSIS BY END-USERS
- 7.1 Overview by End-Users
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End-Users
- 7.4 Hospitals Historic and Forecast Sales by Regions
- 7.5 Cancer Therapy Centres Historic and Forecast Sales by Regions
- 7.6 Others (Speciality Clinics) Historic and Forecast Sales by Regions
8 . GLOBAL SMALL CELL LUNG CANCER (SCLC) THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE SMALL CELL LUNG CANCER (SCLC) THERAPEUTICS COMPANIES
- 9.1. Small Cell Lung Cancer (Sclc) Therapeutics Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF SMALL CELL LUNG CANCER (SCLC) THERAPEUTICS INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. ZIOPHARM Oncology
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. GlaxoSmithKline
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Menarini
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Bristol-Myers Squibb
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Sanofi
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Novartis AG
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Elekta AB
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Siemens Healthcare GmbH
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. G1 Therapeutics.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Treatment Type (USD MN)
- Chemotherapy Market Sales by Geography (USD MN)
- Targeted Therapy Market Sales by Geography (USD MN)
- Immunotherapy Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by End-Users (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Cancer Therapy Centres Market Sales by Geography (USD MN)
- Others (Speciality Clinics) Market Sales by Geography (USD MN)
- Global Small Cell Lung Cancer (Sclc) Therapeutics Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Small Cell Lung Cancer (Sclc) Therapeutics Report
- Market Research Process
- Market Research Methodology
- Global Small Cell Lung Cancer (Sclc) Therapeutics Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Treatment Type
- Market Attractiveness Analysis by End-Users
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Treatment Type (USD MN)
- Chemotherapy Market Sales by Geography (USD MN)
- Targeted Therapy Market Sales by Geography (USD MN)
- Immunotherapy Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-Users (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Cancer Therapy Centres Market Sales by Geography (USD MN)
- Others (Speciality Clinics) Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Companies Market Share Analysis
